You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 康德萊醫械漲逾4%創新高 2019年度淨利潤預增超55%
格隆匯 02-17 10:50
格隆匯2月17日丨康德萊醫械(1501.HK)去年累漲15%,今年迄今已累漲逾36%,且今日盤中股價觸及43港元再創上市新高。現報42.4港元,漲4.18%,暫成交323萬港元,最新總市值70億港元。康德萊醫械上週五(14日)盤後發公告稱,預計集團截至2019年12月31日止年度的淨利潤,將會較上年同期淨利潤增長超過55%。預增的主要原因是:(i)集團期內收入增加;及(ii)集團進一步優化產品結構,將產能更多地投入到生產和銷售具有更高毛利率的介入類產品。此外據悉,定製式醫療器械監督管理規定(試行)已於今年1月1日起生效,對生產、使用定製式醫療器械的生產企業和醫療機構均提出了明確要求,明確定製式醫療器械不得委託生產。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account